Search for Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase Using Chemical Similarity, Molecular Docking, and MM-GB/SA Scoring
- 20 October 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 47 (6) , 2416-2428
- https://doi.org/10.1021/ci700271z
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- From Docking False-Positive to Active Anti-HIV AgentJournal of Medicinal Chemistry, 2007
- Molecular mechanics methods for predicting protein–ligand bindingPhysical Chemistry Chemical Physics, 2006
- Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptaseBioorganic & Medicinal Chemistry Letters, 2005
- Virtual Ligand Screening against Escherichia coli Dihydrofolate Reductase: Improving Docking Enrichment Using Physics-Based MethodsSLAS Discovery, 2005
- Structural and Energetic Analyses of the Effects of the K103N Mutation of HIV-1 Reverse Transcriptase on Efavirenz AnaloguesJournal of Medicinal Chemistry, 2004
- The Many Roles of Computation in Drug DiscoveryScience, 2004
- Potency of Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) Used in Combination with Other Human Immunodeficiency Virus NNRTIs, NRTIs, or Protease InhibitorsAntimicrobial Agents and Chemotherapy, 2002
- Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance 1 1Edited by J. KarnJournal of Molecular Biology, 1998
- Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse TranscriptaseJournal of Molecular Biology, 1994
- Semianalytical treatment of solvation for molecular mechanics and dynamicsJournal of the American Chemical Society, 1990